Catalyst Wire Dossier Catalyst Wire Dossier

Opevesostat

MK-5684 · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Opevesostat, covering 2024-10-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017) [Phase 1]

See pricing